221 related articles for article (PubMed ID: 17261810)
1. SUMO modification regulates inactivation of the voltage-gated potassium channel Kv1.5.
Benson MD; Li QJ; Kieckhafer K; Dudek D; Whorton MR; Sunahara RK; Iñiguez-Lluhí JA; Martens JR
Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1805-10. PubMed ID: 17261810
[TBL] [Abstract][Full Text] [Related]
2. Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension.
Remillard CV; Tigno DD; Platoshyn O; Burg ED; Brevnova EE; Conger D; Nicholson A; Rana BK; Channick RN; Rubin LJ; O'connor DT; Yuan JX
Am J Physiol Cell Physiol; 2007 May; 292(5):C1837-53. PubMed ID: 17267549
[TBL] [Abstract][Full Text] [Related]
3. Ca
Silveirinha VC; Lin H; Tanifuji S; Mochida S; Cottrell GS; Cimarosti H; Stephens GJ
Cell Calcium; 2021 Jan; 93():102326. PubMed ID: 33360835
[TBL] [Abstract][Full Text] [Related]
4. Purification and activity assays for Ubc9, the ubiquitin-conjugating enzyme for the small ubiquitin-like modifier SUMO.
Yunus AA; Lima CD
Methods Enzymol; 2005; 398():74-87. PubMed ID: 16275321
[TBL] [Abstract][Full Text] [Related]
5. CRMP2 protein SUMOylation modulates NaV1.7 channel trafficking.
Dustrude ET; Wilson SM; Ju W; Xiao Y; Khanna R
J Biol Chem; 2013 Aug; 288(34):24316-31. PubMed ID: 23836888
[TBL] [Abstract][Full Text] [Related]
6. Preferential expression and function of voltage-gated, O2-sensitive K+ channels in resistance pulmonary arteries explains regional heterogeneity in hypoxic pulmonary vasoconstriction: ionic diversity in smooth muscle cells.
Archer SL; Wu XC; Thébaud B; Nsair A; Bonnet S; Tyrrell B; McMurtry MS; Hashimoto K; Harry G; Michelakis ED
Circ Res; 2004 Aug; 95(3):308-18. PubMed ID: 15217912
[TBL] [Abstract][Full Text] [Related]
7. Redox-sensitive sulfenic acid modification regulates surface expression of the cardiovascular voltage-gated potassium channel Kv1.5.
Svoboda LK; Reddie KG; Zhang L; Vesely ED; Williams ES; Schumacher SM; O'Connell RP; Shaw R; Day SM; Anumonwo JM; Carroll KS; Martens JR
Circ Res; 2012 Sep; 111(7):842-53. PubMed ID: 22843785
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of cardiac Kv1.5 potassium current by the anesthetic midazolam: mode of action.
Vonderlin N; Fischer F; Zitron E; Seyler C; Scherer D; Thomas D; Katus HA; Scholz EP
Drug Des Devel Ther; 2014; 8():2263-71. PubMed ID: 25422586
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity.
Sentis S; Le Romancer M; Bianchin C; Rostan MC; Corbo L
Mol Endocrinol; 2005 Nov; 19(11):2671-84. PubMed ID: 15961505
[TBL] [Abstract][Full Text] [Related]
10. Covalent conjugation of Groucho with SUMO-1 modulates its corepressor activity.
Ahn JW; Lee YA; Ahn JH; Choi CY
Biochem Biophys Res Commun; 2009 Jan; 379(1):160-5. PubMed ID: 19101520
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of voltage-gated potassium channel Kv1.5--impact on cardiac excitability.
Wettwer E; Terlau H
Curr Opin Pharmacol; 2014 Apr; 15():115-21. PubMed ID: 24632326
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation.
Ji Z; Degerny C; Vintonenko N; Deheuninck J; Foveau B; Leroy C; Coll J; Tulasne D; Baert JL; Fafeur V
Oncogene; 2007 Jan; 26(3):395-406. PubMed ID: 16862185
[TBL] [Abstract][Full Text] [Related]
13. Role for myosin-V motor proteins in the selective delivery of Kv channel isoforms to the membrane surface of cardiac myocytes.
Schumacher-Bass SM; Vesely ED; Zhang L; Ryland KE; McEwen DP; Chan PJ; Frasier CR; McIntyre JC; Shaw RM; Martens JR
Circ Res; 2014 Mar; 114(6):982-92. PubMed ID: 24508725
[TBL] [Abstract][Full Text] [Related]
14. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
15. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
16. Separation of P/C- and U-type inactivation pathways in Kv1.5 potassium channels.
Kurata HT; Doerksen KW; Eldstrom JR; Rezazadeh S; Fedida D
J Physiol; 2005 Oct; 568(Pt 1):31-46. PubMed ID: 16020465
[TBL] [Abstract][Full Text] [Related]
17. Repression of Smad4 transcriptional activity by SUMO modification.
Long J; Wang G; He D; Liu F
Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
[TBL] [Abstract][Full Text] [Related]
18. An extended consensus motif enhances the specificity of substrate modification by SUMO.
Yang SH; Galanis A; Witty J; Sharrocks AD
EMBO J; 2006 Nov; 25(21):5083-93. PubMed ID: 17036045
[TBL] [Abstract][Full Text] [Related]
19. Role for SUMO modification in facilitating transcriptional repression by BKLF.
Perdomo J; Verger A; Turner J; Crossley M
Mol Cell Biol; 2005 Feb; 25(4):1549-59. PubMed ID: 15684403
[TBL] [Abstract][Full Text] [Related]
20. Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1).
Poukka H; Karvonen U; Janne OA; Palvimo JJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14145-50. PubMed ID: 11121022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
